[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
October 3, 1980

Diabetes Mellitus and the Pneumococcus

Author Affiliations

Ware Professor of Diabetes University of Pennsylvania School of Medicine Philadelphia
From the Department of Research Medicine, the School of Medicine, the University of Pennsylvania Medical Center, Philadelphia.

JAMA. 1980;244(14):1573-1574. doi:10.1001/jama.1980.03310140031023

THE COMMENTARY on "Pneumococcus Infection in Diabetes Mellitus: Is This a Justification for Immunization?"1 raises an interesting issue. It may indeed be true that the attack rate of pneumococcal pneumonia in well-regulated diabetics is no higher than that in the nondiabetic population, although data to confirm or to refute this view are lacking. The view set forth by the author that "diabetic ketoacidosis is precipitated by infection" is widely held by those knowledgeable about diabetes mellitus. The cited COMMENTARY also states that vascular changes in the course of diabetes may affect a number of organs, including the kidneys and heart, the ultimate failure of which would be a detriment to resistance to pneumococcal infection.

Value of Prophylaxis  The question of the value of prophylaxis for pneumococcal infection may be approached from several points of view. One is to look at the incidence of such infection and to make a judgment